Stent makers brace for new heart study
(AP)


<p><a href="http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/ap/20070323/ap_on_he_me/stents_vs__drugs"><img src="http://d.yimg.com/us.yimg.com/p/ap/20070323/capt.60fc95bab504496e97e5b3647fdda730.stents_vs__drugs_bx301.jpg?x=130&y=92&sig=y71fBnRAWKZkUaec_MMZmw--" align="left" height="92" width="130" alt="This is an undated photo provided by Boston Scientific that shows the drug-coated Taxus Express Paclitaxel Eluding Coronary Stent System. Wall Street analysts and many doctors expect another potential setback for makers of stents when results of a blockbuster study Tuesday will answer whether an artery-opening procedure plus drugs is better than medication alone for lower-risk heart patients with chest pain. (AP Photo/Boston Scientific, File)" border="0" /></a>AP - Wall Street analysts and many doctors expect another potential setback for makers of stents when results of a blockbuster study Tuesday will answer whether an artery-opening procedure plus drugs is better than medication alone for lower-risk heart patients with chest pain.</p><br clear="all"/>

Read more...